Literature DB >> 1962107

Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature.

M Kristjansson1, V M Bieluch, P D Byeff.   

Abstract

Mycobacterium haemophilum, previously characterized as an unusual pathogen, is found primarily in immunocompromised hosts. This organism has stringent growth characteristics and may not be isolated using routine techniques. M. haemophilum infects the skin and underlying tissues, a circumstance which reflects the organism's propensity for growth in a cooler environment. Infections have been reported in renal transplant recipients, patients with Hodgkin's disease, and, more recently, patients with AIDS. The organism has also been isolated from children with cervical lymphadenitis in the absence of apparent immunodeficiency. Response to therapy has not been uniform, and in some instances improvement in immune status has been associated with regression of lesions. With proliferation of transplantation surgery, chemotherapy, and AIDS, the number of infections due to M. haemophilum is likely to increase.

Entities:  

Mesh:

Year:  1991        PMID: 1962107     DOI: 10.1093/clinids/13.5.906

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  15 in total

1.  Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy.

Authors:  Z Samra; L Kaufmann; A Zeharia; S Ashkenazi; J Amir; J Bahar; U Reischl; L Naumann
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 2.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 3.  Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.

Authors:  M A Saubolle; T E Kiehn; M H White; M F Rudinsky; D Armstrong
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Mycobacterium haemophilum and Histoplasma capsulatum coinfection in a renal transplant patient.

Authors:  Cecilia G Clement; Michael J Loeffelholz; Mahmoud A Eltorky; Yi-Wei Tang; Natalie Williams-Bouyer
Journal:  J Clin Microbiol       Date:  2011-06-29       Impact factor: 5.948

Review 5.  Mycobacterium haemophilum: an emerging pathogen.

Authors:  T E Kiehn; M White
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

6.  DNA polymorphisms detected in Mycobacterium haemophilum by pulsed-field gel electrophoresis.

Authors:  M A Yakrus; W L Straus
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

7.  Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum.

Authors:  K Kikuchi; E M Bernard; T E Kiehn; D Armstrong; L W Riley
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

8.  Intracellular growth and cytotoxicity of Mycobacterium haemophilum in a human epithelial cell line (Hec-1-B).

Authors:  L J Fischer; F D Quinn; E H White; C H King
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Biochemical properties and fatty acid composition of Mycobacterium haemophilum: study of 16 isolates from Australian patients.

Authors:  F Portaels; D J Dawson; L Larsson; L Rigouts
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

10.  Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum.

Authors:  E M Bernard; F F Edwards; T E Kiehn; S T Brown; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.